Lindblad Expeditions Holdings Inc
F:LI4
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Lindblad Expeditions Holdings Inc
F:LI4
|
US |
|
L
|
Lumentum Holdings Inc
XBER:LU2
|
US |
|
N
|
Novartis AG
DUS:NOT
|
CH |
|
G
|
General Motors Co
XMUN:8GM
|
US |
|
Bradespar SA
F:FXM
|
BR |
|
Huaneng Power International Inc
F:HUP
|
CN |
|
Lu-Ve SpA
F:V92
|
IT |
|
L
|
Leggett & Platt Inc
DUS:LP1
|
US |
|
A
|
Anika Therapeutics Inc
F:AKP
|
US |
|
Materialise NV
NASDAQ:MTLS
|
BE |
|
Bankinter SA
MAD:BKT
|
ES |
|
S
|
STORE Capital Corp
F:S76
|
US |
|
F
|
Fresh Del Monte Produce Inc
DUS:FDM
|
US |
|
U
|
USANA Health Sciences Inc
XMUN:USJ
|
US |
|
G
|
Garmin Ltd
XHAM:GEY
|
CH |
Wall St Price Targets
LI4 Price Targets Summary
Lindblad Expeditions Holdings Inc
According to Wall Street analysts, the average 1-year price target for LI4 is 13.83 EUR with a low forecast of 9.57 EUR and a high forecast of 15.8 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is LI4's stock price target?
Price Target
13.83
EUR
According to Wall Street analysts, the average 1-year price target for LI4 is 13.83 EUR with a low forecast of 9.57 EUR and a high forecast of 15.8 EUR.
What is the Revenue forecast for Lindblad Expeditions Holdings Inc?
Projected CAGR
7%
Over the last 12 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 3 years is 7%.
What is the Operating Income forecast for Lindblad Expeditions Holdings Inc?
Projected CAGR
23%
Over the last 12 years, the compound annual growth rate for Operating Income has been 6%. The projected CAGR for the next 3 years is 23%.
